The Hepatic Sinusoid in Aging and Cirrhosis
暂无分享,去创建一个
Robin Fraser | L. Rivory | A. Mclean | David G. Le Couteur | Sarah Kilmer | Laurent P. Rivory | Allan J. McLean | D. Couteur | R. Fraser | S. Kilmer
[1] H. Popper,et al. Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.
[2] W. A. Day,et al. High perfusion pressure damages the sieving ability of sinusoidal endothelium in rat livers. , 1980, British journal of experimental pathology.
[3] Michael S Roberts,et al. Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug. , 2002, The Journal of pharmacology and experimental therapeutics.
[4] N. Hirooka,et al. HEPATIC MICROCIRCULATION OF LIVER CIRRHOSIS STUDIED BY CORROSION CAST/SCANNING ELECTRON MICROSCOPE EXAMINATION , 1986, Acta pathologica japonica.
[5] V. Rodighiero. Effects of Liver Disease on Pharmacokinetics , 1999, Clinical pharmacokinetics.
[6] P. J. Harvey,et al. Acute oxygen supplementation restores markers of hepatocyte energy status and hypoxia in cirrhotic rats. , 2000, The Journal of pharmacology and experimental therapeutics.
[7] M. Roberts,et al. Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver , 2002, Hepatology.
[8] D. L. Le Couteur,et al. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. , 1999, The Journal of pharmacology and experimental therapeutics.
[9] M. Rowland,et al. Correlation between in‐vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model , 1986, The Journal of pharmacy and pharmacology.
[10] P. J. Harvey,et al. 31P and 1H NMR spectroscopic studies of liver extracts of carbon tetrachloride‐treated rats , 1999, NMR in biomedicine.
[11] J. Handler,et al. Hepatobiliary function in senescent male sprague‐dawley rats , 1994, Hepatology.
[12] G. Belforte,et al. Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method. , 1998, The Journal of laboratory and clinical medicine.
[13] H. Popper. Aging and the liver. , 1986, Progress in liver diseases.
[14] C. Rose,et al. Flow‐limited tracer oxygen distribution in the isolated perfused rat liver: Effects of temperature and hematocrit , 1992, Hepatology.
[15] C. Goresky,et al. Transport, binding, and metabolism of sulfate conjugates in the liver. , 1994, Chemico-biological interactions.
[16] H. Maeta,et al. Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry. , 2002, The Journal of surgical research.
[17] P. Angus,et al. Comparative effects of oxygen supplementation on theophylline and acetaminophen clearance in human cirrhosis. , 1999, Gastroenterology.
[18] J. Henriksen,et al. Alcoholic liver injury: Defenestration in noncirrhotic livers—a scanning electron microscopic study , 1987, Hepatology.
[19] O Pelkonen,et al. Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions , 1997, Clinical pharmacology and therapeutics.
[20] A. Mclean,et al. The Aging Liver , 1998, Clinical pharmacokinetics.
[21] G. Rogers,et al. Lipoproteins and the liver sieve: The role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis , 1995, Hepatology.
[22] P. Angus,et al. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver. , 1996, Gastroenterology.
[23] G. Koning,et al. On the mechanism of hepatic transendothelial passage of large liposomes , 1999, FEBS letters.
[24] J. Reichen. The Role of the Sinusoidal Endothelium in Liver Function. , 1999, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[25] W. A. Day,et al. Nicotine decreases the porosity of the rat liver sieve: a possible mechanism for hypercholesterolaemia. , 1988, British journal of experimental pathology.
[26] D. Morgan,et al. Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease , 1991, Hepatology.
[27] E. Wisse,et al. The liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of disse , 1985, Hepatology.
[28] A. Mclean,et al. Age-Environment and Gene-Environment Interactions in the Pathogenesis of Parkinson's Disease , 2002, Reviews on environmental health.
[29] G. Granneman,et al. Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid Chromatography , 1995, Clinical pharmacokinetics.
[30] R. Fraser,et al. The transport of cholesterol in thoracic duct lymph of animals fed cholesterol with varying triglyceride loads. , 1969, The Australian journal of experimental biology and medical science.
[31] D. Morgan,et al. Clinical Pharmacokinetics in Patients with Liver Disease , 1991, Clinical pharmacokinetics.
[32] F Varin,et al. Hepatic microcirculation in the perfused cirrhotic rat liver. , 1985, The Journal of clinical investigation.
[33] P. Richardson,et al. Liver blood flow. II. Effects of drugs and hormones on liver blood flow. , 1981, Gastroenterology.
[34] R. Branch,et al. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. , 1979, Gastroenterology.
[35] G. Harms,et al. Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules , 2004, Histochemistry.
[36] J. Villeneuve,et al. Hepatic circulation in cirrhosis. , 1985, Clinics in gastroenterology.
[37] M. Anwer,et al. Altered hepatobiliary transport of taurocholic acid in aged rats , 1980, Mechanisms of Ageing and Development.
[38] D. P. Jones,et al. Hypoxia and drug metabolism. , 1981, Biochemical pharmacology.
[39] D. L. Le Couteur,et al. Age‐related pseudocapillarization of the human liver , 2003, The Journal of pathology.
[40] C. Florén. Binding of apolipoprotein E-rich remnant lipoproteins to human liver membranes. , 1984, Scandinavian journal of gastroenterology.
[41] D. L. Le Couteur,et al. Carbon monoxide disposition and permeability-surface area product in the foetal circulation of the perfused term human placenta. , 2003, Placenta.
[42] R. Oxner,et al. DEFENESTRATION OF HEPATIC SINUSOIDS AS A CAUSE OF HYPERLIPOPROTEINAEMIA IN ALCOHOLICS , 1988, The Lancet.
[43] H. Wynne,et al. Age-Related Changes in Liver Size and Hepatic Blood Flow , 1988 .
[44] P. J. Harvey,et al. Pseudocapillarization and associated energy limitation in the aged rat liver , 2001, Hepatology.
[45] D. L. Schmucker. Liver Function and Phase I Drug Metabolism in the Elderly , 2001, Drugs & aging.
[46] W. Cliff,et al. The effect of dietary fat load on the size and composition of chylomicrons in thoracic duct lymph. , 1968, Quarterly journal of experimental physiology and cognate medical sciences.
[47] S. Pond,et al. Aging, acute oxidative injury and hepatocellular glucose transport in the rat , 1995 .
[48] R. Branch,et al. Propranolol Disposition in Chronic Liver Disease: A Physiological Approach , 1976, Clinical pharmacokinetics.
[49] Hydrodynamic effects on the solute transport across endothelial pores and hepatocyte membranes. , 2000, Physics in medicine and biology.
[50] I. Wanless,et al. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies , 1996, Hepatology.
[51] D. L. Le Couteur,et al. Carbon monoxide wash-in method to determine gas transfer in vascular beds: application to rat hindlimb. , 2001, American journal of physiology. Heart and circulatory physiology.
[52] D. L. Le Couteur,et al. Carbon monoxide disposition in the perfused rat liver. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[53] J. Villeneuve,et al. Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple‐indicator dilution technique , 1993, Hepatology.
[54] S. Dechambre,et al. Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. , 2002, Clinical science.
[55] A. Mclean,et al. Hepatic sinusoidal pseudocapillarization with aging in the non-human primate , 2003, Experimental Gerontology.
[56] M. Roberts,et al. Structure-hepatic disposition relationships for phenolic compounds. , 1999, Toxicology and applied pharmacology.
[57] L. Zocchi,et al. Macromolecule transfer through mesothelium and connective tissue. , 2000, Journal of applied physiology.
[58] Filip Braet,et al. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review , 2002, Comparative hepatology.
[59] A. Mclean,et al. Hepatic pseudocapillarisation and atherosclerosis in ageing , 2002, The Lancet.
[60] C. Goresky,et al. Uptake of materials by the intact liver. The exchange of glucose across the cell membranes. , 1974, The Journal of clinical investigation.
[61] P. Ott,et al. Interpretation of Simultaneous Measurements of Hepatic Extraction Fractions of Indocyanine Green and Sorbitol , 2000, Digestive Diseases and Sciences.
[62] C. Goresky,et al. A linear method for determining liver sinusoidal and extravascular volumes. , 1963, The American journal of physiology.
[63] G. Geisslinger,et al. Drug Acetylation in Liver Disease , 1998, Clinical pharmacokinetics.
[64] Malcolm Rowland,et al. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance , 1977, Journal of Pharmacokinetics and Biopharmaceutics.
[65] C. Rose,et al. Limitations of Tracer Oxygen Uptake in the Canine Coronary Circulation , 1985, Circulation research.
[66] S. Lowden,et al. Pathways of interstitial fluid and lymph flow in the liver acinus of the sheep and mouse , 1998, Journal of anatomy.
[67] W. A. Day,et al. Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis. , 1978, Atherosclerosis.
[68] T. Okanoue,et al. Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis , 1993, Hepatology.
[69] J. Villeneuve,et al. The hepatic microcirculation in the isolated perfused human liver , 1996, Hepatology.
[70] P. Angus,et al. Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats. , 1995, Gastroenterology.
[71] B. Rippe,et al. Transendothelial Transport: The Vesicle Controversy , 2002, Journal of Vascular Research.
[72] D. Morgan,et al. Clinical Pharmacokinetic and Pharmacodynamic Considerations in Patients with Liver Disease , 1995, Clinical pharmacokinetics.
[73] Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[74] J S Harmatz,et al. Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly , 1991, Clinical pharmacokinetics.
[75] Michael S. Roberts,et al. A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations , 1986, Journal of Pharmacokinetics and Biopharmaceutics.
[76] J S Harmatz,et al. Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly , 2012, Clinical pharmacokinetics.
[77] C. Goresky,et al. On the uptake of materials by the intact liver. The transport and net removal of galactose. , 1973, The Journal of clinical investigation.
[78] J. Villeneuve,et al. Assessment of liver microcirculation in human cirrhosis. , 1982, The Journal of clinical investigation.
[79] M. Bendayan. Vascular permeability in blood capillary , 2002, Microscopy research and technique.
[80] W. Cherry,et al. Uptake of a protein‐bound polar compound, acetaminophen sulfate, by perfused rat liver , 1992, Hepatology.
[81] T. Okanoue,et al. Role of sinusoidal endothelial cells in liver disease , 1995, Journal of gastroenterology and hepatology.
[82] P. Angus,et al. Effect of cirrhosis on sulphation by the isolated perfused rat liver. , 1999, Journal of hepatology.
[83] J. Villeneuve,et al. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat , 1993, Hepatology.
[84] D. L. Le Couteur,et al. The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. , 1994, Transplantation.